Acology Inc. Opening South-East Asia Markets

CORONA, CA--(Marketwired - February 16, 2016) - Today Acology Inc. (OTC PINK: ACOL) announced that progress has been made placing its signature product, The MedTainer™, in medical facilities and hospitals in South Asia markets. The Government of the Philippines has expressed an interest in making The MedTainer an integral part of nation-wide programs focusing on its growing palliative-care industries.

Acology management has focused a great deal of attention and resources in the past 12 months on introducing The MedTainer in global markets and targeting medical services industries in particular. The ability of The MedTainer to effectively grind pills and herbal supplements and the additional benefit of being a cost-effective, clean and safe method of increasing medication control for aging populations, has begun to gather increased attention from medical professionals and administrators throughout the region. Presentations, emphasizing licensing and implementation, will take place in Manila next month.

In other news, Acology has successfully stopped several manufacturers based in China from selling counterfeit products in this and other countries. Having established a pattern of stringent surveillance and vigorous defense of its patented and trademarked products, Acology has barred sales with the cooperation of website giants Ali Baba, Made-In-China and DHGate.com.

Safe Harbor Statement

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 201 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends" and "believes" "estimate" "targets" and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Acology Inc. and D&C Distributors are located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880. Acology trades on the OTC under the call letters ACOL. The company's email is www.Acologyinc.com. Please send inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649)